Literature DB >> 19076487

Stop the presses: dissociating a selective from a global mechanism for stopping.

Adam R Aron1, Frederick Verbruggen.   

Abstract

How does one control an inappropriate tendency? Many studies have investigated this question by measuring the speed with which subjects stop an initiated response. Yet the rapid stopping of an initiated response is apparently underpinned by a neurocognitive mechanism that has global effects on multiple tendencies. This limits such studies as models of cognitive control because they do not explain the selectivity of control over particular tendencies that is apparent in everyday life. We hypothesized that subjects employ a selective stopping mechanism when they have foreknowledge of which response to stop, but employ a global stopping mechanism when they do not have such foreknowledge. Comparing foreknowledge and no-foreknowledge conditions, we show that when subjects have foreknowledge, stopping is indeed more selective, as evidenced by less of an effect on the concurrent execution of an alternative response; however, stopping is also slower when subjects have foreknowledge. Thus, selective and global mechanisms of stopping can be dissociated. We suggest that the selective mechanism is used when people maintain the goal of controlling particular responses, whereas the global mechanism is used when it is essential to stop quickly.

Entities:  

Mesh:

Year:  2008        PMID: 19076487     DOI: 10.1111/j.1467-9280.2008.02216.x

Source DB:  PubMed          Journal:  Psychol Sci        ISSN: 0956-7976


  58 in total

1.  The role of the right presupplementary motor area in stopping action: two studies with event-related transcranial magnetic stimulation.

Authors:  Weidong Cai; Jobi S George; Frederick Verbruggen; Christopher D Chambers; Adam R Aron
Journal:  J Neurophysiol       Date:  2012-04-18       Impact factor: 2.714

2.  Functional parcellation of the inferior frontal and midcingulate cortices in a flanker-stop-change paradigm.

Authors:  Stefanie Enriquez-Geppert; Tom Eichele; Karsten Specht; Harald Kugel; Christo Pantev; René J Huster
Journal:  Hum Brain Mapp       Date:  2012-03-16       Impact factor: 5.038

3.  Aging and inhibitory control of action: cortico-subthalamic connection strength predicts stopping performance.

Authors:  James P Coxon; Annouchka Van Impe; Nicole Wenderoth; Stephan P Swinnen
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

4.  Stopping a response has global or nonglobal effects on the motor system depending on preparation.

Authors:  Ian Greenhouse; Caitlin L Oldenkamp; Adam R Aron
Journal:  J Neurophysiol       Date:  2011-10-19       Impact factor: 2.714

Review 5.  Response inhibition in the stop-signal paradigm.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  Trends Cogn Sci       Date:  2008-11       Impact factor: 20.229

6.  Having a goal to stop action is associated with advance control of specific motor representations.

Authors:  Michael P Claffey; Sarah Sheldon; Cathy M Stinear; Frederick Verbruggen; Adam R Aron
Journal:  Neuropsychologia       Date:  2009-10-29       Impact factor: 3.139

7.  Transcranial magnetic stimulation reveals dissociable mechanisms for global versus selective corticomotor suppression underlying the stopping of action.

Authors:  D S Adnan Majid; Weidong Cai; Jobi S George; Frederick Verbruggen; Adam R Aron
Journal:  Cereb Cortex       Date:  2011-06-10       Impact factor: 5.357

8.  Nonselective motor-level changes associated with selective response inhibition: evidence from response force measurements.

Authors:  Yao-Ting Ko; Jeff Miller
Journal:  Psychon Bull Rev       Date:  2011-08

9.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

Review 10.  Models of response inhibition in the stop-signal and stop-change paradigms.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  Neurosci Biobehav Rev       Date:  2008-09-04       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.